Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors

Michael A. Hauser, Ann Robinson, Dennis Hartigan-O'Connor, DeeAnn Williams-Gregory, Jean N. Buskin, Steve Apone, Christopher J. Kirk, Stephen Hardy, Stephen D. Hauschka, Jeffrey S. Chamberlain

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Adenoviral gene transfer holds promise for gene therapy, but effective transduction of a large and distributed tissue such as muscle will almost certainly require systemic delivery. In this context, the use of muscle-specific regulatory elements such asthe muscle creatine kinase (MCK) promoter and enhancer will avoid potentially harmful ectopic expression of transgenes. We describe here the development and testing of adenoviral vectors contain ing small, striated muscle-specific, highly active MCK expression cassettes. One of these regulatory elements (CK6) is less than 600 bp in length and is 12% as active as the CMV promoter/enhancer in muscle. A recombinant adenoviral vector containing this regulatory element retains very high muscle specificity, expressing 600-fold higher levels of transgene in muscle than in liver. Muscle-specific regulatory elements may also increase persistence of transduced muscle cells Adenoviral transduction of dendritic cells has been shown to stimulate cytotoxic T-lymphocyte (CTL) responses directed against transgene epitopes. We show that human dendritic cells infected in vitro with MCK-containing adenoviruses do not express significant levels of transgene. Furthermore, while adenoviral vectors containing nonspecific promoters are normally cleared from muscle tissue within 1 month, we show that MCK-containing vectors express significant levels of transgene 4 months after intramuscular injection.

Original languageEnglish (US)
Pages (from-to)16-25
Number of pages10
JournalMolecular Therapy
Volume2
Issue number1
DOIs
StatePublished - Jul 2000
Externally publishedYes

Fingerprint

MM Form Creatine Kinase
Transgenes
Muscles
Dendritic Cells
Striated Muscle
Intramuscular Injections
Cytotoxic T-Lymphocytes
Adenoviridae
Genetic Therapy
Muscle Cells
Epitopes
Liver

Keywords

  • Adenovirus
  • Dendritic cell
  • Muscle creatine kinase
  • Muscle-specific
  • Muscular dystrophy

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Hauser, M. A., Robinson, A., Hartigan-O'Connor, D., Williams-Gregory, D., Buskin, J. N., Apone, S., ... Chamberlain, J. S. (2000). Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors. Molecular Therapy, 2(1), 16-25. https://doi.org/10.1006/mthe.2000.0089

Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors. / Hauser, Michael A.; Robinson, Ann; Hartigan-O'Connor, Dennis; Williams-Gregory, DeeAnn; Buskin, Jean N.; Apone, Steve; Kirk, Christopher J.; Hardy, Stephen; Hauschka, Stephen D.; Chamberlain, Jeffrey S.

In: Molecular Therapy, Vol. 2, No. 1, 07.2000, p. 16-25.

Research output: Contribution to journalArticle

Hauser, MA, Robinson, A, Hartigan-O'Connor, D, Williams-Gregory, D, Buskin, JN, Apone, S, Kirk, CJ, Hardy, S, Hauschka, SD & Chamberlain, JS 2000, 'Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors', Molecular Therapy, vol. 2, no. 1, pp. 16-25. https://doi.org/10.1006/mthe.2000.0089
Hauser, Michael A. ; Robinson, Ann ; Hartigan-O'Connor, Dennis ; Williams-Gregory, DeeAnn ; Buskin, Jean N. ; Apone, Steve ; Kirk, Christopher J. ; Hardy, Stephen ; Hauschka, Stephen D. ; Chamberlain, Jeffrey S. / Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors. In: Molecular Therapy. 2000 ; Vol. 2, No. 1. pp. 16-25.
@article{0be0bd187b694de68ab10b4efffbd01f,
title = "Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors",
abstract = "Adenoviral gene transfer holds promise for gene therapy, but effective transduction of a large and distributed tissue such as muscle will almost certainly require systemic delivery. In this context, the use of muscle-specific regulatory elements such asthe muscle creatine kinase (MCK) promoter and enhancer will avoid potentially harmful ectopic expression of transgenes. We describe here the development and testing of adenoviral vectors contain ing small, striated muscle-specific, highly active MCK expression cassettes. One of these regulatory elements (CK6) is less than 600 bp in length and is 12{\%} as active as the CMV promoter/enhancer in muscle. A recombinant adenoviral vector containing this regulatory element retains very high muscle specificity, expressing 600-fold higher levels of transgene in muscle than in liver. Muscle-specific regulatory elements may also increase persistence of transduced muscle cells Adenoviral transduction of dendritic cells has been shown to stimulate cytotoxic T-lymphocyte (CTL) responses directed against transgene epitopes. We show that human dendritic cells infected in vitro with MCK-containing adenoviruses do not express significant levels of transgene. Furthermore, while adenoviral vectors containing nonspecific promoters are normally cleared from muscle tissue within 1 month, we show that MCK-containing vectors express significant levels of transgene 4 months after intramuscular injection.",
keywords = "Adenovirus, Dendritic cell, Muscle creatine kinase, Muscle-specific, Muscular dystrophy",
author = "Hauser, {Michael A.} and Ann Robinson and Dennis Hartigan-O'Connor and DeeAnn Williams-Gregory and Buskin, {Jean N.} and Steve Apone and Kirk, {Christopher J.} and Stephen Hardy and Hauschka, {Stephen D.} and Chamberlain, {Jeffrey S.}",
year = "2000",
month = "7",
doi = "10.1006/mthe.2000.0089",
language = "English (US)",
volume = "2",
pages = "16--25",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors

AU - Hauser, Michael A.

AU - Robinson, Ann

AU - Hartigan-O'Connor, Dennis

AU - Williams-Gregory, DeeAnn

AU - Buskin, Jean N.

AU - Apone, Steve

AU - Kirk, Christopher J.

AU - Hardy, Stephen

AU - Hauschka, Stephen D.

AU - Chamberlain, Jeffrey S.

PY - 2000/7

Y1 - 2000/7

N2 - Adenoviral gene transfer holds promise for gene therapy, but effective transduction of a large and distributed tissue such as muscle will almost certainly require systemic delivery. In this context, the use of muscle-specific regulatory elements such asthe muscle creatine kinase (MCK) promoter and enhancer will avoid potentially harmful ectopic expression of transgenes. We describe here the development and testing of adenoviral vectors contain ing small, striated muscle-specific, highly active MCK expression cassettes. One of these regulatory elements (CK6) is less than 600 bp in length and is 12% as active as the CMV promoter/enhancer in muscle. A recombinant adenoviral vector containing this regulatory element retains very high muscle specificity, expressing 600-fold higher levels of transgene in muscle than in liver. Muscle-specific regulatory elements may also increase persistence of transduced muscle cells Adenoviral transduction of dendritic cells has been shown to stimulate cytotoxic T-lymphocyte (CTL) responses directed against transgene epitopes. We show that human dendritic cells infected in vitro with MCK-containing adenoviruses do not express significant levels of transgene. Furthermore, while adenoviral vectors containing nonspecific promoters are normally cleared from muscle tissue within 1 month, we show that MCK-containing vectors express significant levels of transgene 4 months after intramuscular injection.

AB - Adenoviral gene transfer holds promise for gene therapy, but effective transduction of a large and distributed tissue such as muscle will almost certainly require systemic delivery. In this context, the use of muscle-specific regulatory elements such asthe muscle creatine kinase (MCK) promoter and enhancer will avoid potentially harmful ectopic expression of transgenes. We describe here the development and testing of adenoviral vectors contain ing small, striated muscle-specific, highly active MCK expression cassettes. One of these regulatory elements (CK6) is less than 600 bp in length and is 12% as active as the CMV promoter/enhancer in muscle. A recombinant adenoviral vector containing this regulatory element retains very high muscle specificity, expressing 600-fold higher levels of transgene in muscle than in liver. Muscle-specific regulatory elements may also increase persistence of transduced muscle cells Adenoviral transduction of dendritic cells has been shown to stimulate cytotoxic T-lymphocyte (CTL) responses directed against transgene epitopes. We show that human dendritic cells infected in vitro with MCK-containing adenoviruses do not express significant levels of transgene. Furthermore, while adenoviral vectors containing nonspecific promoters are normally cleared from muscle tissue within 1 month, we show that MCK-containing vectors express significant levels of transgene 4 months after intramuscular injection.

KW - Adenovirus

KW - Dendritic cell

KW - Muscle creatine kinase

KW - Muscle-specific

KW - Muscular dystrophy

UR - http://www.scopus.com/inward/record.url?scp=0034218590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034218590&partnerID=8YFLogxK

U2 - 10.1006/mthe.2000.0089

DO - 10.1006/mthe.2000.0089

M3 - Article

C2 - 10899824

AN - SCOPUS:0034218590

VL - 2

SP - 16

EP - 25

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 1

ER -